106 related articles for article (PubMed ID: 27358154)
1. Efficacy and tolerability of a combined lipid-lowering nutraceutical on cholesterolemia, hs-CRP level and endothelial function in moderately hypercholesterolemic subjects.
Cicero AF; Colletti A; Rosticci M; Grandi E; Borghi C
J Biol Regul Homeost Agents; 2016; 30(2):593-8. PubMed ID: 27358154
[TBL] [Abstract][Full Text] [Related]
2. Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects.
Cicero AF; Derosa G; Parini A; Maffioli P; D'Addato S; Reggi A; Giovannini M; Borghi C
Nutr Res; 2013 Aug; 33(8):622-8. PubMed ID: 23890351
[TBL] [Abstract][Full Text] [Related]
3. Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects.
Cicero AF; Morbini M; Parini A; Urso R; Rosticci M; Grandi E; Borghi C
Ther Clin Risk Manag; 2016; 12():281-6. PubMed ID: 26966368
[TBL] [Abstract][Full Text] [Related]
4. A Randomized, Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO
Cicero AFG; D'Addato S; Borghi C
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33066334
[TBL] [Abstract][Full Text] [Related]
5. Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial.
Cicero AF; Colletti A; Fogacci F; Bove M; Rosticci M; Borghi C
High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):13-18. PubMed ID: 27339779
[TBL] [Abstract][Full Text] [Related]
6. Middle-Term Dietary Supplementation with Red Yeast Rice Plus Coenzyme Q10 Improves Lipid Pattern, Endothelial Reactivity and Arterial Stiffness in Moderately Hypercholesterolemic Subjects.
Cicero AF; Morbini M; Rosticci M; D''Addato S; Grandi E; Borghi C
Ann Nutr Metab; 2016; 68(3):213-9. PubMed ID: 27055107
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
Feldman T; Davidson M; Shah A; Maccubbin D; Meehan A; Zakson M; Tribble D; Veltri E; Mitchel Y
Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
[TBL] [Abstract][Full Text] [Related]
8. Effects of Campomanesia xanthocarpa on inflammatory processes, oxidative stress, endothelial dysfunction and lipid biomarkers in hypercholesterolemic individuals.
Viecili PR; Borges DO; Kirsten K; Malheiros J; Viecili E; Melo RD; Trevisan G; da Silva MA; Bochi GV; Moresco RN; Klafke JZ
Atherosclerosis; 2014 May; 234(1):85-92. PubMed ID: 24632042
[TBL] [Abstract][Full Text] [Related]
9. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
Bays HE; Davidson M; Jones MR; Abby SL
Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
[TBL] [Abstract][Full Text] [Related]
10. Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.
Cicero AF; Derosa G; Pisciotta L; Barbagallo C;
J Med Food; 2015 Nov; 18(11):1270-3. PubMed ID: 26274827
[TBL] [Abstract][Full Text] [Related]
11. Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.
Ruscica M; Pavanello C; Gandini S; Macchi C; Botta M; Dall'Orto D; Del Puppo M; Bertolotti M; Bosisio R; Mombelli G; Sirtori CR; Calabresi L; Magni P
Nutr J; 2019 Feb; 18(1):13. PubMed ID: 30795775
[TBL] [Abstract][Full Text] [Related]
12. Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial.
Cicero AFG; Fogacci F; Bove M; Veronesi M; Rizzo M; Giovannini M; Borghi C
Adv Ther; 2017 Aug; 34(8):1966-1975. PubMed ID: 28687937
[TBL] [Abstract][Full Text] [Related]
13. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
14. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Effect of a Dietary Supplement Containing Dry Artichoke and Bergamot Extracts on Metabolic and Vascular Risk Factors in Individuals with Suboptimal Cholesterol Levels.
Fogacci F; Giovannini M; Di Micoli A; Fiorini G; Grandi E; Borghi C; Cicero AFG
Nutrients; 2024 May; 16(11):. PubMed ID: 38892519
[TBL] [Abstract][Full Text] [Related]
15. NUtraceutical TReatment for hYpercholesterolemia in HIV-infected patients: The NU-TRY(HIV) randomized cross-over trial.
Pirro M; Francisci D; Bianconi V; Schiaroli E; Mannarino MR; Barsotti F; Spinozzi A; Bagaglia F; Sahebkar A; Baldelli F
Atherosclerosis; 2019 Jan; 280():51-57. PubMed ID: 30471555
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
Lewis JH; Mortensen ME; Zweig S; Fusco MJ; Medoff JR; Belder R;
Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension study.
Masana L; Mata P; Gagné C; Sirah W; Cho M; Johnson-Levonas AO; Meehan A; Troxell JK; Gumbiner B;
Clin Ther; 2005 Feb; 27(2):174-84. PubMed ID: 15811480
[TBL] [Abstract][Full Text] [Related]
18. Effects of colesevelam hydrochloride (WelChol) on biomarkers of inflammation in patients with mild hypercholesterolemia.
Devaraj S; Autret B; Jialal I
Am J Cardiol; 2006 Sep; 98(5):641-3. PubMed ID: 16923452
[TBL] [Abstract][Full Text] [Related]
19. Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia.
Protic O; Di Pillo R; Montesanto A; Galeazzi R; Matacchione G; Giuliani A; Sabbatinelli J; Gurău F; Silvestrini A; Olivieri F; Antonicelli R; Bonfigli AR
Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889769
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.
Marazzi G; Cacciotti L; Pelliccia F; Iaia L; Volterrani M; Caminiti G; Sposato B; Massaro R; Grieco F; Rosano G
Adv Ther; 2011 Dec; 28(12):1105-13. PubMed ID: 22113535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
